ClinVar Miner

Submissions for variant NM_007294.4(BRCA1):c.5133del (p.Lys1711fs)

dbSNP: rs730880288
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) RCV000157653 SCV000300206 pathogenic Breast-ovarian cancer, familial, susceptibility to, 1 2016-09-08 reviewed by expert panel curation Variant allele predicted to encode a truncated non-functional protein.
Strand Center for Genomics and Personalized Medicine, Strand Life Sciences Pvt Ltd RCV000157653 SCV000195858 likely pathogenic Breast-ovarian cancer, familial, susceptibility to, 1 2014-02-19 no assertion criteria provided clinical testing The variant c.5133del is found heterozygously in a female which results in a frameshift variation after Lys1711 leading to premature truncation in the protein. The chromatin structure assay demonstrated that the 1707IAGGK1711 region is critical for the chromatin unfolding activity (PMID: 12674632). A variation p.Gly1710Ter has been reported to be associated with breast cancer in French patients (PMID: 15131401).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.